Keyphrases
Acute Kidney Injury
66%
Alemtuzumab
50%
Antihypertensive Drugs
50%
Atypical Hemolytic Uremic Syndrome (aHUS)
50%
Atypical Presentation
50%
Cardiovascular Disease
25%
Clinical Decisions
50%
Clinical Impact
50%
Clinical Judgment
50%
Clinical Trials
25%
Diabetic Nephropathy
50%
Donation after Cardiac Death
50%
Drug Trials
25%
Graft Failure
19%
High Blood Pressure
50%
International Survey
50%
Joint National Committee
50%
Kidney Transplant Recipients
50%
Kidney Transplantation
79%
Kinetic Estimated Glomerular Filtration Rate
50%
Lifestyle Modification
50%
Liver Transplantation
50%
Measured Creatinine Clearance
50%
Medical Care
50%
Membranous Nephropathy
50%
Meta-analysis
50%
Multicenter Retrospective Cohort Study
50%
Nephrologists
50%
Novel Therapies
25%
Pancreas Transplant Alone
30%
Patient Survival
23%
Patients with Hypertension
50%
Postpartum Period
33%
Preeclampsia
50%
Pregnancy Disorders
50%
Principal Investigator
25%
Randomized Controlled Trial
50%
Renal Denervation
25%
Renal Outcome
25%
Resistant Hypertension
50%
Steroid-free
50%
Systematic Meta-analysis
50%
Tacrolimus
50%
Take-home
50%
Thrombocytopenia
33%
Thrombotic Microangiopathy
100%
Trial Data
50%
Type 2 Diabetes Mellitus (T2DM)
25%
Type 2 Diabetic Patients
25%
Young Women
16%
Medicine and Dentistry
Acute Kidney Injury
66%
Antibodies
5%
Atypical Hemolytic Uremic Syndrome
50%
Bacterial Infection
5%
Cardiovascular Disease
25%
Chronic Kidney Disease
7%
Clinical Significance
16%
Clinical Trial
25%
Complement Membrane Attack Complex
16%
Delayed Diagnosis
16%
Delayed Graft Function
6%
Demography
7%
Diabetic Nephropathy
50%
Diagnosis
16%
Diseases
20%
Drug Screening
25%
Drug Therapy
25%
Eclampsia
16%
Eclampsia and Preeclampsia
16%
Eculizumab
16%
Elevated Transaminases
16%
Graft Survival
20%
Hypertension
50%
Immunosuppressive Treatment
50%
Kidney Denervation
25%
Kidney Transplantation
45%
Lifestyle Modification
50%
Maturity Onset Diabetes of the Young
25%
Medical Care
50%
Membranous Glomerulonephritis
50%
Meta-Analysis
50%
Microangiopathy
50%
Nephrologist
50%
Observational Study
50%
Pancreas Transplantation
50%
Pathophysiology
16%
Patient with Hypertension
50%
Patient with Type 2 Diabetes
25%
Platelet
16%
Pre-Eclampsia
16%
Puerperium
33%
Randomized Controlled Trial
50%
Renal Failure
16%
Renal Replacement Therapy
7%
Resistant Hypertension
50%
Single Drug Dose
50%
Systematic Review
50%
Thrombocytopenia
33%
Thrombotic Thrombocytopenic Purpura
16%
Transplantation
10%
